相关实验视频

Updated: Jul 28, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

比较abrocitinib和dupilumab如何治疗亚托皮性皮肤炎的迹象和症状:一个简单的语言摘要

Kristian Reich¹, Jacob P Thyssen², Andrew Blauvelt³

¹University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

|May 31, 2023

概括

阿布罗西提尼布片有效治疗中度至严重的亚托邦性皮炎 (AD),也称为湿疹,在缓解症状方面表现优于dupilumab. 这种新疗法为患有持续性皮肤疾病的患者提供了一个有前途的选择.

科学领域:

皮肤病学皮肤病学
免疫学免疫学免疫学
临床药理学临床药理学

背景情况:

无氧性皮肤炎 (AD) 是一种慢性炎症性皮肤疾病,其特点是和不适.
目前的治疗方法,包括局部疗法,并不总是足以控制AD症状.
阿布罗西替尼 (abrocitinib) 是一种口服药物,向与阿尔茨海默病发病有关的免疫反应.

研究的目的:

为了比较abrocitinib与dupilumab在中度至重度AD的成年人中的疗效和安全性.
为了评估与abrocitinib治疗的症状和皮肤迹象改善的速度和程度.

主要方法:

在JADE DARE临床研究中,AD患者接受了26周的治疗.
阿布罗西提尼布 (口服片) 与杜皮卢马布 (注射药物) 进行了比较.
关键的结果包括缓解和改善可见的皮肤迹象.

主要成果:

与dupilumab相比,abrocitinib在第2周表现出优异的的缓解.
在第4周和第16周使用abrocitinib时,观察到AD可见皮肤症状的更大改善.
在abrocitinib和dupilumab之间,不良事件的发生率是可比的,大多数是轻微的.

结论:

阿布罗西替尼比dupilumab.com提供了一个比dupilumab.com更有效和更快速的治疗选择,用于中度至重度的AD.
这项研究支持abrocitinib作为一种有价值的治疗选择,用于那些对常规治疗反应不足的患者.

关键词:

抗体治疗药物抗体治疗药物临床免疫学临床免疫学临床试验的设计.皮肤学皮肤学免疫疗法免疫疗法

更多相关视频

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...